Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DIVISLAB | NSE
-17.00
-0.27%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
6,361.50
6,408.50
6,442.50
6,320.00
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates and nutraceutical ingredients in India the United States Asia Europe and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids as well as markets vitamins to nutritional pharma food/beverage and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad India.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
20.0%1 month
17.4%3 months
23.9%6 months
21.9%95.24
-
11.89
0.00
0.00
59.26
19.38
-
23.29B
1,704.25B
17.94B
0.50
24.84
20.80
19.10
12.15
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
538.50
Range1M
822.00
Range3M
1.15K
Rel. volume
0.96
Price X volume
2.02B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | TORNTPHARM | Drug Manufacturers-Specialty & Generic | 4117.2 | 1,393.45B | -0.72% | 66.22 | 58.66% |
| Cipla Limited | CIPLA | Drug Manufacturers-Specialty & Generic | 1295 | 1,050.86B | -0.83% | 29.26 | 2.09% |
| Lupin Limited | LUPIN | Drug Manufacturers-Specialty & Generic | 2296.1 | 1,047.35B | -1.93% | 44.05 | 20.45% |
| Zydus Lifesciences Limited | ZYDUSLIFE | Drug Manufacturers-Specialty & Generic | 927.4 | 932.77B | -2.00% | 24.72 | 4.06% |
| Mankind Pharma Ltd | MANKIND | Drug Manufacturers-Specialty & Generic | 2267.4 | 908.42B | -1.11% | 54.23 | 2.21% |
| Aurobindo Pharma Limited | AUROPHARMA | Drug Manufacturers-Specialty & Generic | 1413.8 | 821.14B | -1.50% | 24.51 | 22.28% |
| Glenmark Pharmaceuticals Limited | GLENMARK | Drug Manufacturers-Specialty & Generic | 2299.5 | 648.89B | -1.52% | n/a | 15.68% |
| Alkem Laboratories Limited | ALKEM | Drug Manufacturers-Specialty & Generic | 5235 | 625.92B | -5.17% | 35.71 | 13.75% |
| Laurus Labs Limited | LAURUSLABS | Drug Manufacturers-Specialty & Generic | 1113.45 | 600.33B | -1.38% | 172.16 | 62.70% |
| Biocon Limited | BIOCON | Biotechnology | 349.85 | 417.75B | -2.28% | 25.67 | 64.84% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Trent Limited | TRENT | Apparel Retail | 4297.3 | 1,537.21B | 1.08% | 161.30 | 43.09% |
| Hindustan Copper Limited | HINDCOPPER | Copper | 541.5 | 523.64B | -1.45% | 87.06 | 9.74% |
| AFFLE | AFFLE | Advertising Agencies | 1406.7 | 196.73B | -1.82% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 450.05 | 110.08B | -2.65% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 50.36 | 44.18B | -2.59% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 59.26 | 24.85 | Expensive |
| Ent. to Revenue | 19.38 | 11.40 | Expensive |
| PE Ratio | 95.24 | 51.36 | Expensive |
| Price to Book | 11.89 | 6.83 | Expensive |
| Dividend Yield | 0.50 | 0.52 | Par |
| Std. Deviation (3M) | 23.94 | 42.17 | Lower Risk |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 1,704.25B | 290.82B | Market Leader |